treatment for drug-resistant TB - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

How AbraSilver Resource Corp. is using Condoryacu to widen the strategic upside at Diablillos before feasibility results (TSX: ABRA)

What this small Australia acquisition reveals about Arthur J. Gallagher & Co.’s bigger strategy (NYSE: AJG)

What the Blacklane acquisition means for Uber Technologies, Inc.’s luxury and corporate travel ambitions (NYSE: UBER)

Why Flex Ltd.’s $1.1bn EP2 acquisition signals rising confidence in U.S. grid modernization spending (NASDAQ: FLEX)

Johnson & Johnson's TB drug SIRTURO receives full FDA and EC approval, enhancing treatment for resistant tuberculosis. Read more about this major healthcare breakthrough.

Read More

Pharma Industry News

Johnson & Johnson’s TB drug SIRTURO receives full approval from FDA and EC

In a significant development for the treatment of drug-resistant tuberculosis (TB), Johnson & Johnson has announced that SIRTURO…

byPallavi Madhiraju

July 7, 2024

web analytics